• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of Thyroid Hormone on Urinary Concentrating Ability.甲状腺激素对尿液浓缩能力的影响。
Eur Thyroid J. 2017 Sep;6(5):238-242. doi: 10.1159/000478521. Epub 2017 Jul 3.
2
RENAL FUNCTION AND PLASMA RENIN ACTIVITY AS POTENTIAL FACTORS CAUSING HYPERKALEMIA IN PATIENTS WITH THYROID CARCINOMA UNDERGOING THYROID HORMONE WITHDRAWAL FOR RADIOACTIVE IODINE THERAPY.肾功能和血浆肾素活性可能是甲状腺癌患者在接受放射性碘治疗行甲状腺激素撤除后发生高钾血症的原因。
Endocr Pract. 2020 Feb;26(2):197-206. doi: 10.4158/EP-2019-0374. Epub 2019 Oct 25.
3
Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer.分化型甲状腺癌放射性碘治疗期间甲状腺激素撤药对代谢和心血管参数的影响
J Int Med Res. 2017 Feb;45(1):38-50. doi: 10.1177/0300060516664242. Epub 2016 Nov 18.
4
Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?甲状腺功能减退症和甲状腺切除术后患者经左甲状腺素治疗后促甲状腺激素-甲状腺激素反馈控制敏感性降低。血清三碘甲状腺原氨酸是否参与其中?
Ann Endocrinol (Paris). 2018 Apr;79(2):62-66. doi: 10.1016/j.ando.2017.11.003. Epub 2018 Mar 9.
5
Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.与原发性甲状腺疾病相比,TSH 缺乏症的甲状腺功能减退症的诊断和治疗:垂体患者接受左甲状腺素替代治疗不足的风险更高。
Clin Endocrinol (Oxf). 2011 Jun;74(6):744-9. doi: 10.1111/j.1365-2265.2011.03984.x.
6
Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.接受左甲状腺素单一疗法的甲状腺切除患者中反映甲状腺功能的生化标志物
Thyroid. 2017 Apr;27(4):484-490. doi: 10.1089/thy.2016.0426. Epub 2017 Feb 6.
7
Serum microRNA profiles in athyroid patients on and off levothyroxine therapy.甲状腺功能减退症患者在服用及停用左甲状腺素治疗时的血清 microRNA 谱。
PLoS One. 2018 Apr 12;13(4):e0194259. doi: 10.1371/journal.pone.0194259. eCollection 2018.
8
Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.因补充钙或铁导致治疗不足的甲状腺功能减退症,通过口服左甲状腺素液得到纠正。
Endocrine. 2017 Apr;56(1):138-145. doi: 10.1007/s12020-017-1244-2. Epub 2017 Feb 3.
9
Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.血清I型胶原羧基末端交联肽(ICTP)水平在促甲状腺激素不适当分泌综合征鉴别诊断中的应用
Clin Endocrinol (Oxf). 1997 Aug;47(2):207-14. doi: 10.1046/j.1365-2265.1997.2351057.x.
10
Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment.老年人甲状腺功能减退症:病理生理学、诊断与治疗
Drugs Aging. 2005;22(1):23-38. doi: 10.2165/00002512-200522010-00002.

引用本文的文献

1
Subclinical Hyperthyroidism Presenting as Urinary Frequency and Polyuria: A Case Report.以尿频和多尿为表现的亚临床甲状腺功能亢进症:一例报告
Cureus. 2025 Jul 18;17(7):e88251. doi: 10.7759/cureus.88251. eCollection 2025 Jul.
2
The Correlation Between Impaired Thyroid Hormone Sensitivity and Diabetic Nephropathy in Euthyroid Patients with Type 2 Diabetes Mellitus.甲状腺功能正常的2型糖尿病患者甲状腺激素敏感性受损与糖尿病肾病的相关性
Diabetes Metab Syndr Obes. 2025 Apr 23;18:1207-1221. doi: 10.2147/DMSO.S507750. eCollection 2025.
3
Emerging pathogens and from a Canadian tertiary care hospital.新兴病原体和来自加拿大三级保健医院的。
Future Microbiol. 2024;19(15):1321-1332. doi: 10.1080/17460913.2024.2383503. Epub 2024 Aug 7.
4
Urine concentrating ability in cats with hyperthyroidism: Influence of radioiodine treatment, masked azotemia, and iatrogenic hypothyroidism.甲状腺功能亢进症猫的尿液浓缩能力:放射性碘治疗、隐匿性氮质血症和医源性甲状腺功能减退症的影响。
J Vet Intern Med. 2023 Nov-Dec;37(6):2039-2051. doi: 10.1111/jvim.16849. Epub 2023 Sep 5.
5
Effect of withdrawal of thyroid hormones versus administration of recombinant human thyroid-stimulating hormone on renal function in thyroid cancer patients.甲状腺激素停药与重组人促甲状腺激素给药对甲状腺癌患者肾功能的影响。
Sci Rep. 2023 Jan 5;13(1):206. doi: 10.1038/s41598-023-27455-0.

本文引用的文献

1
Hypothyroidism and hyponatremia: data from a series of patients with iatrogenic acute hypothyroidism undergoing radioactive iodine therapy after total thyroidectomy for thyroid cancer.甲状腺功能减退症与低钠血症:来自一系列因甲状腺癌行全甲状腺切除术后接受放射性碘治疗的医源性急性甲状腺功能减退症患者的数据。
J Endocrinol Invest. 2017 Jan;40(1):49-54. doi: 10.1007/s40618-016-0525-6. Epub 2016 Aug 9.
2
Molecular Physiology of Water Balance.水平衡的分子生理学
N Engl J Med. 2015 Jul 9;373(2):196. doi: 10.1056/NEJMc1505505.
3
Low iodine diet in differentiated thyroid cancer: a review.分化型甲状腺癌的低碘饮食:综述
Clin Endocrinol (Oxf). 2016 Jan;84(1):3-12. doi: 10.1111/cen.12846. Epub 2015 Jul 29.
4
Hypothyroidism and reversible kidney dysfunction: an essential relationship to recognize.甲状腺功能减退与可逆性肾功能不全:一种需要认识的重要关系。
Endocr Pract. 2014 May;20(5):490-9. doi: 10.4158/EP12084.RA.
5
The renal manifestations of thyroid disease.甲状腺疾病的肾脏表现。
J Am Soc Nephrol. 2012 Jan;23(1):22-6. doi: 10.1681/ASN.2010070766. Epub 2011 Oct 21.
6
How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer.重组人促甲状腺素的可获得性如何改变了甲状腺癌患者的管理。
Nat Clin Pract Endocrinol Metab. 2007 Sep;3(9):641-50. doi: 10.1038/ncpendmet0594.
7
Polyuria of thyrotoxicosis: downregulation of aquaporin water channels and increased solute excretion.甲状腺毒症性多尿:水通道蛋白水通道下调与溶质排泄增加
Kidney Int. 2007 Nov;72(9):1088-94. doi: 10.1038/sj.ki.5002475. Epub 2007 Aug 15.
8
Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism.甲状腺功能减退症患者尿稀释功能受损时血管加压素和肾水通道蛋白的非渗透性释放
Am J Physiol Renal Physiol. 2005 Oct;289(4):F672-8. doi: 10.1152/ajprenal.00384.2004. Epub 2005 May 24.
9
Hypothyroidism.甲状腺功能减退症
Lancet. 2004 Mar 6;363(9411):793-803. doi: 10.1016/S0140-6736(04)15696-1.
10
Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy.严重甲状腺功能减退及甲状腺激素替代治疗后的同位素肾功能研究。
Am J Nephrol. 2004 Jan-Feb;24(1):41-5. doi: 10.1159/000075628. Epub 2003 Dec 17.

甲状腺激素对尿液浓缩能力的影响。

Effects of Thyroid Hormone on Urinary Concentrating Ability.

作者信息

Massolt Elske T, Salih Mahdi, Beukhof Carolien M, Kam Boen L R, Burger J W, Visser W Edward, Hoorn Ewout J, Peeters Robin P

机构信息

Division of Endocrinology, Erasmus MC, Rotterdam, The Netherlands.

Rotterdam Thyroid Center, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.

出版信息

Eur Thyroid J. 2017 Sep;6(5):238-242. doi: 10.1159/000478521. Epub 2017 Jul 3.

DOI:10.1159/000478521
PMID:29071235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5649223/
Abstract

BACKGROUND

Hypothyroidism has been associated with impaired urinary concentrating ability. However, previous reports on thyroid hormone and urinary concentrating ability in humans only studied a limited number of patients with autoimmune thyroid disease or used healthy controls instead of paired analysis within the same patients.

OBJECTIVE

To study the urinary concentrating ability in athyreotic patients with differentiated thyroid cancer on and off levothyroxine treatment as they are exposed to different thyroid states as part of their treatment in the absence of an autoimmune disease.

DESIGN AND METHODS

We studied 9 patients (mean age of 42.7 years) during severe hypothyroid state (withdrawal of levothyroxine before radioactive iodine therapy) and TSH-suppressed state (on levothyroxine therapy). At these two points, serum and urine samples were collected after 14 h of overnight fasting without any food or drink.

RESULTS

Serum and urine osmolality were not significantly different between on and off levothyroxine treatment. Serum creatinine levels were significantly higher in patients off versus on levothyroxine treatment (87.0 vs. 71.0 µmol/L, respectively; = 0.044) and, correspondingly, the estimated glomerular filtration rate was significantly lower (89.6 vs. 93.1 mL/min, respectively; = 0.038).

CONCLUSION

Short-term, severe hypothyroidism has no effect on urinary concentrating ability. Our study confirms the well-known effects of thyroid hormone on serum creatinine concentrations.

摘要

背景

甲状腺功能减退与尿浓缩能力受损有关。然而,先前关于人类甲状腺激素与尿浓缩能力的报告仅研究了少数自身免疫性甲状腺疾病患者,或使用健康对照而非对同一患者进行配对分析。

目的

研究分化型甲状腺癌无甲状腺患者在左甲状腺素治疗期间及停药时的尿浓缩能力,因为在无自身免疫性疾病的情况下,他们在治疗过程中会经历不同的甲状腺状态。

设计与方法

我们研究了9名患者(平均年龄42.7岁),分别处于严重甲状腺功能减退状态(放射性碘治疗前停用左甲状腺素)和促甲状腺激素抑制状态(接受左甲状腺素治疗)。在这两个时间点,过夜禁食14小时且未进食或饮水后采集血清和尿液样本。

结果

左甲状腺素治疗期间及停药时,血清和尿渗透压无显著差异。停药患者的血清肌酐水平显著高于用药患者(分别为87.0和71.0µmol/L;P = 0.044),相应地,估计肾小球滤过率显著更低(分别为89.6和93.1 mL/min;P = 0.038)。

结论

短期、严重的甲状腺功能减退对尿浓缩能力无影响。我们的研究证实了甲状腺激素对血清肌酐浓度的已知影响。